US Stock MarketDetailed Quotes

ANTX AN2 Therapeutics

Watchlist
  • 1.030
  • -1.610-60.98%
Close Aug 9 16:00 ET
  • 1.010
  • -0.020-1.93%
Post 19:58 ET
30.72MMarket Cap-410P/E (TTM)

AN2 Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

AN2 Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.56

+29.11%
Analyst Rating

Buy

Aug 9, 2024

AN2 Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

AN2 Therapeutics Earnings Reports

  • AN2 Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 14 16:19 ET

  • AN2 Therapeutics | 10-K/A: Annual report (Amendment)

    May 14 16:06 ET

  • AN2 Therapeutics | 10-K: FY2023 Annual Report

    Mar 29 16:28 ET

  • AN2 Therapeutics: Q3 2023 Earnings Report

    Nov 9, 2023 16:15 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 9, 2024

    Buy

    • Buy

      60.00%

    • Hold

      20.00%

    • Sell

      20.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg